Pages that link to "Q57321283"
Jump to navigation
Jump to search
The following pages link to Jeffrey P MacKeigan (Q57321283):
Displaying 46 items.
- Leaving the lysosome behind: novel developments in autophagy inhibition (Q26774549) (← links)
- Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor (Q27659041) (← links)
- A mitochondrial RNAi screen defines cellular bioenergetic determinants and identifies an adenylate kinase as a key regulator of ATP levels (Q28238894) (← links)
- Identification of small molecule inhibitors of PTPσ through an integrative virtual and biochemical approach (Q28485264) (← links)
- Bidirectional transport of amino acids regulates mTOR and autophagy (Q29614476) (← links)
- Activation of a metabolic gene regulatory network downstream of mTOR complex 1 (Q29615179) (← links)
- Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system (Q30446265) (← links)
- Identification of PTPsigma as an autophagic phosphatase. (Q30498183) (← links)
- Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response. (Q30540705) (← links)
- From sequence to function: using RNAi to elucidate mechanisms of human disease. (Q33315240) (← links)
- DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways. (Q33607399) (← links)
- Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. (Q33756854) (← links)
- Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression (Q33772820) (← links)
- The genomic landscape of tuberous sclerosis complex (Q33826893) (← links)
- Graded mitogen-activated protein kinase activity precedes switch-like c-Fos induction in mammalian cells. (Q33837052) (← links)
- Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib (Q33878944) (← links)
- STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma. (Q34154674) (← links)
- Downregulation of the mitochondrial phosphatase PTPMT1 is sufficient to promote cancer cell death (Q34323114) (← links)
- Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas (Q34533693) (← links)
- A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. (Q34551716) (← links)
- Tailoring tyrosine kinase inhibitors to fit the lung cancer genome. (Q34754045) (← links)
- Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery. (Q34967191) (← links)
- MK-STYX, a catalytically inactive phosphatase regulating mitochondrially dependent apoptosis (Q35102064) (← links)
- Persistent mitochondrial hyperfusion promotes G2/M accumulation and caspase-dependent cell death (Q35121876) (← links)
- Mitochondrial morphological features are associated with fission and fusion events (Q35148029) (← links)
- Computational analysis of an autophagy/translation switch based on mutual inhibition of MTORC1 and ULK1 (Q35168438) (← links)
- Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing (Q35705859) (← links)
- Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex. (Q36250754) (← links)
- Mitochondrial phosphorylation in apoptosis: flipping the death switch. (Q37029131) (← links)
- Characterization of differential protein tethering at the plasma membrane in response to epidermal growth factor signaling (Q37092245) (← links)
- Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new. (Q37728343) (← links)
- Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities. (Q38693843) (← links)
- Synthesis of improved lysomotropic autophagy inhibitors (Q38897106) (← links)
- Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets (Q39530418) (← links)
- Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death. (Q39993130) (← links)
- PI3K-C2α knockdown decreases autophagy and maturation of endocytic vesicles. (Q41070521) (← links)
- Dual Roles of Fer Kinase Are Required for Proper Hematopoiesis and Vascular Endothelium Organization during Zebrafish Development (Q47099394) (← links)
- Development of a Center for Personalized Cancer Care at a Regional Cancer Center: Feasibility Trial of an Institutional Tumor Sequencing Advisory Board (Q48016091) (← links)
- Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. (Q53358479) (← links)
- A Potent and Selective ULK1 Inhibitor Suppresses Autophagy and Sensitizes Cancer Cells to Nutrient Stress (Q57191934) (← links)
- Determining the Impact of Metabolic Nutrients on Autophagy (Q57454732) (← links)
- Identification of Kinases Responsible for p53-Dependent Autophagy (Q64097152) (← links)
- MEK inhibition enhances paclitaxel-induced tumor apoptosis (Q73093705) (← links)
- Origins of cancer (Q84973022) (← links)
- Patient-Derived Xenograft Models of Colorectal Cancer: Procedures for Engraftment and Propagation (Q88198050) (← links)
- LRRK2 deficiency impairs trans-Golgi to lysosome trafficking and endocytic cargo degradation in human renal proximal tubule epithelial cells (Q90835371) (← links)